close icon

Geberit to Flush 40% of Gains Down the Drain

Geberit Group is one of the largest sanitary technology and bathroom ceramics providers in the world. Headquartered in Switzerland, the company operates through the Bathroom, Piping, Installation and Flushing Systems segments.

Founded in 1874, its stock trades on the SIX Swiss Exchange under the symbol GEBN. Less than two years after its early-2000 IPO, the stock price fell to CHF 29 in September 2001. In the twenty years that followed, however, Geberit’s market value rose by almost 1900%. The stock closed at CHF 540 two days ago.

And while Geberit’s financials and business performance are nothing short of stellar, we think this is not a good time to join the bulls. The company’s price to earnings ratio stands at 32, which is quite expensive. This is not the only reason to abstain from buying, though. One can even argue that in a zero-rate world quality companies deserve to trade at a premium. Instead, what really bothers us is the chart below and the Elliott Wave pattern it reveals.

Geberit stock to enter Elliott Wave correction

GEBN’s weekly chart shows that the uptrend from its 2001 bottom is a textbook five-wave impulse. The pattern is labeled (1)-(2)-(3)-(4)-(5) and has been developing within the parallel lines of a trend channel. The impulsive structure of wave (3) is also visible and marked 1-2-3-4-5.

Geberit Can Lose as Much as 40% in Elliott Wave Correction

The market has apparently taken the guideline of alternation into account, as well. Wave (2) was a sharp and steady decline to the 61.8% Fibonacci support during the Financial crisis. Wave (4), on the other hand, was a sideways-moving running flat correction which culminated in the COVID-19 crash earlier this year.

If the analysis so far is correct, the recovery Geberit shareholders have been enjoying over the past nine months must be wave (5). It helped the stock reach a new all-time high of CHF 576 in November. The problem is that according to the Elliott Wave theory, a three-wave correction follows every impulse.

So it turns out Geberit is not only fundamentally overvalued, but vulnerable from a technical standpoint, as well. Corrections usually erase the entire fifth wave. In GEBN’s case, a ~40% drop to roughly CHF 330 can be expected over the next couple of years.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!

Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Undervalued Bristol Myers Stock Can Still Get Cheaper

It’s been almost two years since we shared our bullish stance on Bristol Myers stock. Shares in the pharmaceutical major were changing hands for less than $46 in April, 2019. The company had just announced its planned acquisition of Celgene for about $74 billion and Wall Street apparently didn’t like the risks involved. However, the…

Read More »

DraftKings on the Verge of Another 40% Decline

It’s been almost three and a half months since we examined DraftKings stock in October, 2020. The share price was hovering near $57 after a strong run from $10.60 to over $64 in just several months. The regulatory environment in the U.S. seemed to be warming up and many analysts hurried to issue their BUY…

Read More »

AMN Healthcare Stock to Suffer a 2020-Like Drop

AMN Healthcare Services provides workforce and staffing solutions to healthcare facilities in the U.S. The company is relatively small with a market capitalization of less than $4 billion. However, small companies can make for excellent returns if one happens to identify the winners. And indeed, between late-2011 and early-2020, AMN stock from under $4 to…

Read More »

Zoetis Stock Getting Ahead of Itself, Invites Correction

Based in Parsippany, NJ, Zoetis Inc. is an animal medicine and vaccine developer and manufacturer. The company went public in 2013 and has been enjoying steady growth since. With the stock currently above $160 a share, Zoetis holds a market cap of nearly $80 billion. For a profitable and growing company like Zoetis, a rising…

Read More »

CBOE Stock Looking Good After a Record Year

CBOE Global Markets Inc. is an equities, options and futures exchange operator in the U.S. and Europe. The company traces its roots back to Chicago in 1973, when it practically invented options trading in its present form. CBOE is literally part of the very infrastructure of modern financial markets. So it is not surprising that…

Read More »

Novo Nordisk Bulls Have an Elliott Wave Problem

Novo Nordisk A/S is a Danish pharmaceuticals major with a market cap of over $160 billion. People need their medication even in recessions, so the company’s business wasn’t as affected by the 2020 crisis as most other industries. Novo Nordisk remains a top-notch pharma with consistent profits and revenue and no debt whatsoever. And the…

Read More »

Lockheed ‘s Correction Still Unfolding as Expected

Almost a year and a half ago, in July 2019, we wrote that Lockheed Martin is likely “setting the stage for an unpleasant surprise.” The stock had just reached a new all-time high and was trading at $370 a share. Optimism was in the air and analysts were more bullish than ever. An indeed, fundamentally,…

Read More »

More analyses